Data gathered: April 15
AI Stock Analysis - Bioventus (BVS)
Analysis generated March 26, 2025. Powered by Chat GPT.
Bioventus is a global medical device company that leverages its existing active healing therapies to enhance healing and alleviate pain by aiding in the body's natural healing process. The company primarily focuses on ortho-biologics, which include treatments created from various biological sources aimed at improving musculoskeletal health. Bioventus continually seeks innovative solutions to address complex medical conditions.
Stock Alerts - Bioventus (BVS)
 |
Bioventus | April 10 Price is down by -5.4% in the last 24h. |
|
Bioventus | April 9 Price is up by 5.8% in the last 24h. |
|
Bioventus | April 8 Price is down by -5.4% in the last 24h. |
|
Bioventus | April 7 Price is down by -6.9% in the last 24h. |
Alternative Data for Bioventus
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 33 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 9,000 | Sign up | Sign up | Sign up |
| Employee Rating | 84 | Sign up | Sign up | Sign up |
| Google Trends | 32 | Sign up | Sign up | Sign up |
| Patents | 13 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | N/A | Sign up | Sign up | Sign up |
| Facebook Followers | 626 | Sign up | Sign up | Sign up |
| Instagram Followers | 689 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 2 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 422 | Sign up | Sign up | Sign up |
| Twitter Followers | 1,852 | Sign up | Sign up | Sign up |
| Twitter Mentions | 5 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 25,100 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 87 | Sign up | Sign up | Sign up |
| Linkedin Employees | 1,101 | Sign up | Sign up | Sign up |
About Bioventus
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body’s natural healing process in the United States and internationally.
| Price | $7.92 |
| Target Price | Sign up |
| Volume | 370,280 |
| Market Cap | $495M |
| Year Range | $7.46 - $13.71 |
| Dividend Yield | 0% |
| Analyst Rating | 67% buy |
| Industry | Medical Devices |
In the news
 |
ExodusPoint Capital Management LP Reduces Position in Bioventus Inc. (NYSE:BVS)April 14 - ETF Daily News |
|
Trexquant Investment LP Has $467,000 Stock Holdings in Bioventus Inc. (NYSE:BVS)April 13 - ETF Daily News |
|
KLP Kapitalforvaltning AS Takes Position in Bioventus Inc. (NYSE:BVS)April 12 - ETF Daily News |
 |
Here's Why Bioventus (BVS) Is a Great 'Buy the Bottom' Stock NowMarch 30 - Yahoo |
|
Intech Investment Management LLC Increases Stake in Bioventus Inc. (NYSE:BVS)March 27 - ETF Daily News |
|
Bioventus Inc. (NYSE:BVS) Position Boosted by Bank of New York Mellon CorpMarch 24 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q4 '24 | 155M | 142M | 103M | -160,000 | 9.8M | 0.150 |
| Q3 '24 | 139M | 131M | 94M | -4.8M | 6.1M | 0.060 |
| Q2 '24 | 151M | 176M | 104M | -24M | -27M | 0.190 |
| Q1 '24 | 129M | 121M | 88M | -4.6M | -1.7M | 0.070 |
| Q4 '23 | 135M | 130M | 86M | -6.1M | -4.5M | 0.070 |
Insider Transactions View All
| Singleton Mark Leonard filed to sell 131,963 shares at $9.8. March 25 '25 |
| D'Adamio Anthony filed to sell 124,449 shares at $9.8. March 18 '25 |
| CHURCH KATRINA J filed to sell 52,540 shares at $9.8. March 18 '25 |
| CHURCH KATRINA J filed to sell 50,102 shares at $10.2. February 20 '25 |
| D'Adamio Anthony filed to sell 118,178 shares at $10.2. February 20 '25 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Boston ScientificBSX |
$94.27 0% | 72 |
 |
Edwards LifesciencesEW |
$69.87 0% | 32 |
 |
Intuitive SurgicalISRG |
$490.13 0% | 66 |
 |
MedtronicMDT |
$84.22 0% | 47 |
 |
StrykerSYK |
$353.42 0% | 48 |
Read more about Bioventus (BVS) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Bioventus?
The Market Cap of Bioventus is $495M.
What is the current stock price of Bioventus?
Currently, the price of one share of Bioventus stock is $7.92.
How can I analyze the BVS stock price chart for investment decisions?
The BVS stock price chart above provides a comprehensive visual representation of Bioventus' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Bioventus shares. Our platform offers an up-to-date BVS stock price chart, along with technical data analysis and alternative data insights.
Does BVS offer dividends to its shareholders?
As of our latest update, Bioventus (BVS) does not offer dividends to its shareholders. Investors interested in Bioventus should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Bioventus?
Some of the similar stocks of Bioventus are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.